DEVELOPMENT OF A SELECTION-BASED TECHNOLOGY (SELEX) TO ISOLATE BIOMOLECULES CAPABLE TO SPECIFICALLY ACTIVATE THE RET GENE, ENCODING THE TRANSDUCING COMPONENT OF THE GDNF RECEPTOR
- 2 Anni 1997/1999
- 51.646€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 2000-03-01 CANCER RESEARCH
High levels of tyrosine phosphorylated proto-Ret in sporadic pheochromocytomas
- 2000-06-23 JOURNAL OF BIOLOGICAL CHEMISTRY
Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells
- 2000-06-23 JOURNAL OF BIOLOGICAL CHEMISTRY
Abrogation of nerve growth factor-induced terminal differentiation by ret oncogene involves perturbation of nuclear translocation of ERK
- 2000-01-01 ONCOLOGY
Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas
- 2002-01-01 ONCOLOGY
5′-end RET splicing:: Absence of variants in normal tissues and intron retention in pheochromocytomas
